Join
Live feed
·
PRReleasevia Quantisnow
Reata Pharmaceuticals Inc. logo

Reata Pharmaceuticals, Inc. to Report Third Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on November 8, 2022

ByQuantisnow·Wall Street's wire, on your screen.
RETA· Reata Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RETA (Reata Pharmaceuticals Inc.) and more on Quantisnow.